Jiang LC, Tang SX. Keap1-Nrf2-ARE signaling pathway and gastric cancer chemoprevention.
Shijie Huaren Xiaohua Zazhi 2014;
22:2845-2850. [DOI:
10.11569/wcjd.v22.i20.2845]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Nuclear factor E2-related factor 2 (Nrf2) plays an important role in the body's anti-oxidative stress system. Although Nrf2 can prevent the malignant transformation of normal cells, it also can promote tumor development and increase the resistance of tumor cells to chemotherapeutic drugs. Gastric cancer is one of the most common malignant tumors of the digestive system with high mortality, posing a serious threat to human health. Since chemotherapy resistance is common in cancer treatment, cancer chemoprevention has become a hot spot of tumor treatment. The Keap1-Nrf2-ARE signaling pathway is related to the occurrence of gastric cancer, representing a molecular target for gastric cancer chemoprevention. This paper summarizes the recent progress in understanding the relationship between the Keap1-Nrf2-ARE signaling pathway and gastric cancer chemoprevention.
Collapse